Econ Healthcare’s ebitda came in 2.9% y-o-y lower for the full year at $16.4 million, and its ebitda margin declined by 17.7% y-o-y to 32.3%.
Catalist-listed Econ Healthcare (Asia) has reported earnings of $6.3 million for FY2024 ended Mar 31, 2024, a 8% y-o-y growth from the same period a year before.
The group’s patmi from continuing operations margin however, saw a 8.5% decrease to 12.4% for the full year, from 13.6% in the same period a year ago.
